Nithesh Babu Ramesh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nithesh Babu Ramesh has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Abinaya Srinivasa Rangan
Saveetha Institute of Medical and Technical Sciences, Saveetha University, Department of General Medicine, Chennai, India
1 shared publication - Fathima S Nilofar
Department of General Medicine, Saveetha Medical College Hospital, Thandalam, Chennai, Tamil Nadu, India
1 shared publication - I Mariraj
Saveetha Medical College Hospital, Thandalam, Chennai, Tamil Nadu, India
1 shared publication - Neha Nanditha Adepu
Osmania Medical College, Department of MBBS, Telangana, India
1 shared publication - Prasanna Venkatesh
Mahatma Gandhi Medical College and Research Institute. Sri Balaji vidyapeeth (deemed to be university), Department of General Medicine. Pondicherry, India
1 shared publication - Saranya Palaniswamy
Saveetha University
1 shared publication
Latest Publications
- Open Access
- 20 August 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 4, .920
Evaluate the Frequency of EosinophilicEsophagitisin Individuals with Refractory GERD
Background: Theeosinophilic infiltrate of the esophagus mucosal distinguishes the esophageal ailment known as Eosinophilicesophagitis (EoE). This study aims to determine the frequency of EoE in patients with gastroesophageal reflux disease (GERD), a gastro esophageal reflux condition that is persistent. Methods: The 248 children in total hadelectiveupper gastrointestinal endoscopy (UGIE) during the study period were separated in tosix groups: individuals without a history of steroid usage and those with outanesophageal biopsyforthrombocytopenia. As a result, 200 people participated in the study total. Results: After an evaluation of 200 children having elective UGIE, A variety of health problems were found during the investigation, including food bolusimpact (2 %), achalasia cardia (5 %), pepticstricture (6 %), congenitalstricture (3 %), post-esophageal atresia repairanastomoticstricture (4 %), and symptoms of gastro esophageal reflux, including vomiting (10 %), regurgitation (2 %), belchingchest (1,5 %), nocturnal cough (2,5 %), pain/heartburn (12,5 %), and feeding refusal (1 %). There were several unusual illnesses that were observed, including Crohn's disease accounted for 2 %, paediatric intestinal pseudo-obstruction (10 %), abdominal discomfort (17,5 %), celiacdisease (16 %), cow's milk protein allergy (3 %), and un classified IBD (7 %). Conclusion: EoEfrequently affects GERD patients who are recalcitrant to treatment. Dysphagia, food impaction, and heartburn are posible symptoms. EGD and esophageal biopsy should be explored for EoEscreening in elderly individuals with strong GERD who are atopy positive and who have not responded to gastric acid inhibitors.
- 20 August 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 4, .920
Open AccessEvaluate the Frequency of EosinophilicEsophagitisin Individuals with Refractory GERD
Background: Theeosinophilic infiltrate of the esophagus mucosal distinguishes the esophageal ailment known as Eosinophilicesophagitis (EoE). This study aims to determine the frequency of EoE in patients with gastroesophageal reflux disease (GERD), a gastro esophageal reflux condition that is persistent. Methods: The 248 children in total hadelectiveupper gastrointestinal endoscopy (UGIE) during the study period were separated in tosix groups: individuals without a history of steroid usage and those with outanesophageal biopsyforthrombocytopenia. As a result, 200 people participated in the study total. Results: After an evaluation of 200 children having elective UGIE, A variety of health problems were found during the investigation, including food bolusimpact (2 %), achalasia cardia (5 %), pepticstricture (6 %), congenitalstricture (3 %), post-esophageal atresia repairanastomoticstricture (4 %), and symptoms of gastro esophageal reflux, including vomiting (10 %), regurgitation (2 %), belchingchest (1,5 %), nocturnal cough (2,5 %), pain/heartburn (12,5 %), and feeding refusal (1 %). There were several unusual illnesses that were observed, including Crohn's disease accounted for 2 %, paediatric intestinal pseudo-obstruction (10 %), abdominal discomfort (17,5 %), celiacdisease (16 %), cow's milk protein allergy (3 %), and un classified IBD (7 %). Conclusion: EoEfrequently affects GERD patients who are recalcitrant to treatment. Dysphagia, food impaction, and heartburn are posible symptoms. EGD and esophageal biopsy should be explored for EoEscreening in elderly individuals with strong GERD who are atopy positive and who have not responded to gastric acid inhibitors.
- Open Access
- 1 January 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 4, .899
Clinical and Antimicrobial Profile of Acinetobacter Species in Critical Care Setting- An Emerging Nosocomial Bug
Background: The increasing prevalence of multidrug-resistant bacterial infections, particularly within healthcare-associated settings, poses a global public health threat. Among these pathogens, Acinetobacter species, notably Acinetobacter baumannii, have gained recognition as opportunistic nosocomial pathogens with a concerning propensity for antimicrobial resistance. Understanding their clinical and antimicrobial profile is crucial for addressing the challenges posed by these infections.Objectives: To assess the prevalence of Acinetobacter species in distinct clinical samples.To analyze Acinetobacter species' clinical profiles and patterns of antibiotic sensitivity using a range of clinical samples.Materials and Methods: A cross-sectional study was conducted in a tertiary care hospital in South India, approved by the Institutional Ethics Committee. Patients with confirmed Acinetobacter infections were included, and clinical samples were collected from the critical care unit. Demographics, comorbidities, clinical presentations, and outcomes were recorded. Laboratory processing included standard protocols for sample analysis, with confirmation through advanced methods such as PCR.Results: Out of 82 participants, 48.78% showed positive cultures for Acinetobacter species. Prevalence varied by sample type, with urine samples exhibiting the highest positivity (50%). Clinical analysis of 40 infected patients revealed a mean age of 43.72 ± 17.34 years. Musculoskeletal symptoms (17.5%) and obstetric complications (17.5%) were prominent clinical presentations. Antibiotic sensitivity analysis demonstrated that 51% of isolates were multidrug-resistant, with high resistance to key antibiotics. Commonly resistant antibiotics included Cefepime, Piperacillin, Levofloxacin, Imipenem, Meropenem, and Amikacin.Conclusion: This study adds to the growing understanding of Acinetobacter infections, emphasizing the need for awareness, infection control, and judicious antibiotic use. The multidisciplinary clinical presentations and high resistance rates underscore the complexity of managing Acinetobacter infections, requiring a holistic approach in healthcare settings. The findings inform strategies for infection prevention, surveillance, and therapeutic approaches in the global effort to combat antimicrobial resistance
- 1 January 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 4, .899
Open AccessClinical and Antimicrobial Profile of Acinetobacter Species in Critical Care Setting- An Emerging Nosocomial Bug
Background: The increasing prevalence of multidrug-resistant bacterial infections, particularly within healthcare-associated settings, poses a global public health threat. Among these pathogens, Acinetobacter species, notably Acinetobacter baumannii, have gained recognition as opportunistic nosocomial pathogens with a concerning propensity for antimicrobial resistance. Understanding their clinical and antimicrobial profile is crucial for addressing the challenges posed by these infections.Objectives: To assess the prevalence of Acinetobacter species in distinct clinical samples.To analyze Acinetobacter species' clinical profiles and patterns of antibiotic sensitivity using a range of clinical samples.Materials and Methods: A cross-sectional study was conducted in a tertiary care hospital in South India, approved by the Institutional Ethics Committee. Patients with confirmed Acinetobacter infections were included, and clinical samples were collected from the critical care unit. Demographics, comorbidities, clinical presentations, and outcomes were recorded. Laboratory processing included standard protocols for sample analysis, with confirmation through advanced methods such as PCR.Results: Out of 82 participants, 48.78% showed positive cultures for Acinetobacter species. Prevalence varied by sample type, with urine samples exhibiting the highest positivity (50%). Clinical analysis of 40 infected patients revealed a mean age of 43.72 ± 17.34 years. Musculoskeletal symptoms (17.5%) and obstetric complications (17.5%) were prominent clinical presentations. Antibiotic sensitivity analysis demonstrated that 51% of isolates were multidrug-resistant, with high resistance to key antibiotics. Commonly resistant antibiotics included Cefepime, Piperacillin, Levofloxacin, Imipenem, Meropenem, and Amikacin.Conclusion: This study adds to the growing understanding of Acinetobacter infections, emphasizing the need for awareness, infection control, and judicious antibiotic use. The multidisciplinary clinical presentations and high resistance rates underscore the complexity of managing Acinetobacter infections, requiring a holistic approach in healthcare settings. The findings inform strategies for infection prevention, surveillance, and therapeutic approaches in the global effort to combat antimicrobial resistance